Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Ascendis Pharma A/S (ASND) Q1 2026 Earnings
ASND
11
Feb
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q1 2026
-1.66
-1.14
-0.62
-0.09
Details
Expected EPS
-0.0944775844
Actual EPS
-0.6459805
Surprise EPS
-0.55
Surprise Percent
+583.74%
Description
Ascendis Pharma A/S (ASND) has reported earnings of -0.6459805 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login